Linquist Jeanne A, Rosaia Catherine M, Riemer Becky, Heckman Kathy, Alvarez Frank
Department of Medicine, Mills-Peninsula Health Services, Burlingame, California 94010, USA.
Am J Infect Control. 2002 Aug;30(5):307-10. doi: 10.1067/mic.2002.123394.
Patients receiving hemodialysis are generally considered to be at increased risk of developing tuberculosis (TB). We evaluated a 13-station chronic outpatient hemodialysis unit associated with a community hospital in northern California. Within 6 months, there were 2 incident source cases in the unit of active smear positive pulmonary tuberculosis; the first in a health care worker (HCW), diagnosed April 3, 1998, and the second in a patient undergoing dialysis treatment in October 1998. We describe the cases; the evaluation of exposures; and the institution of an intentional prospective TB control plan, designed specifically for the unique hemodialysis setting.
We evaluated 23 HCWs twice and 89 patients undergoing hemodialysis treatment who were exposed to case 1 and 38 patients who were exposed to case 2. All 23 HCWs had documented prior negative Sierbert purified protein derivative of tuberculin (PPD) status and were retested at 12 weeks after exposure. None of the patients had documentation of PPD status. All of the patients were skin-tested initially with use of the 2-step method, and those with positive test results were offered isoniazid (INH).
One of the 23 HCWs' negative baseline PPD skin test status converted after exposure to case 1, and none of the remaining 22 converted after exposure to case 2. Twelve of 89 exposed patients with no prior skin test record had positive results for PPD after initial testing with the 2-step method. Three of the 12 (25%) patients were treated with INH at the discretion of their attending nephrologist. The 77 patients with negative results for PPD still had negative test results when retested at 3 months. None of 38 patients who underwent dialysis on the same schedule as source case 2 had a converted PPD test. Restriction fragment length polymorphism on TB isolates from both source cases ultimately showed them to be unrelated strains.
Our experience with these exposures suggests that TB screening of patient populations undergoing renal dialysis-though they have intrinsic high anergy rates-is advisable with a designed prospective plan before any inadvertent and/or repetitive exposure of that population to active TB. A planned intentional TB control program increases HCW awareness of TB, establishes baselines for evaluation, decreases "panic" in the event of subsequent exposures, and emphasizes the rationale for preventive therapy.
接受血液透析的患者通常被认为患结核病(TB)的风险增加。我们评估了加利福尼亚州北部一家社区医院附属的一个拥有13个站点的慢性门诊血液透析单元。在6个月内,该单元出现了2例涂片阳性的活动性肺结核传染源病例;第一例是一名医护人员(HCW),于1998年4月3日确诊,第二例是一名在1998年10月接受透析治疗的患者。我们描述了这些病例、暴露情况评估以及专门针对独特的血液透析环境制定的前瞻性结核病控制计划的实施情况。
我们对23名医护人员进行了两次评估,对89名接触病例1的血液透析患者和38名接触病例2的患者进行了评估。所有23名医护人员先前结核菌素纯蛋白衍生物(PPD)检测结果均为阴性并有记录,在接触后12周再次进行检测。所有患者均无PPD检测结果记录。所有患者最初均采用两步法进行皮肤检测,检测结果呈阳性的患者给予异烟肼(INH)治疗。
23名医护人员中有1名在接触病例1后,其基线PPD皮肤检测结果由阴性转为阳性,其余22名在接触病例2后均未出现检测结果转换。89名既往无皮肤检测记录的接触患者中,12名在采用两步法进行初次检测后PPD结果呈阳性。12名患者中有3名(25%)由其主治肾病专家酌情给予INH治疗。77名PPD检测结果为阴性的患者在3个月后再次检测时结果仍为阴性。与传染源病例2透析时间表相同的38名患者中,PPD检测结果均未转换。对来自两个传染源病例的结核分枝杆菌分离株进行限制性片段长度多态性分析,最终表明它们是无关菌株。
我们在这些暴露情况中的经验表明,对接受肾透析的患者群体进行结核病筛查——尽管他们本身无反应率较高——在该群体意外和/或反复接触活动性结核病之前,采用设计好的前瞻性计划进行筛查是可取的。有计划的结核病控制项目可提高医护人员对结核病的认识,建立评估基线,在后续接触时减少“恐慌”,并强调预防性治疗的基本原理。